| 2741 |
LEVOPLANT |
LEVONORGESTREL 75 MG |
SUB DERMAL IMPLANT |
POUCH |
CONTRACEPTION |
NULL |
VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD |
SHANGHAI DAHUA PHARMACEUTICAL CO.,LTD |
CHINA |
CERTIFICATE RELEASED |
03 I 5411/23 |
17-Mar-2023 |
16-Mar-2026 |
View |
| 2742 |
LINEZOLID DENK 2 MG/ML |
LINEZOLID 2 MG/ML( 600 MG/300 ML) |
SOLUTION FOR INFUSION |
LDPE BAG |
NOSOCOMIAL PNEUMONIA, COMMUNITY-ACCQUIRED PNEUMONIA, SEVERE SKIN AND SOFT TISSUE INFECTION, |
NULL |
VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD |
PHARMACEUTICAL WORKS POLPHARMA S.A |
GERMANY |
CERTIFICATE RELEASED |
12 I 4854/19 |
19-Apr-2023 |
18-Apr-2026 |
View |
| 2743 |
LOSAR-DENK 100 |
LOSARTAN POTASSIUM 100 MG |
FILM-COATED TABLETS |
ALU/PVC/PE/PVDC BLISTER |
TREATMENT OF ESSENTIAL HYPERTENSION. TREATMENT OF THE RENAL DISEASE IN PATIENTS WITH HYPERTENSION AND TYPE 2 DIABETICS MELLITUS WITH PROTEINURIA OF >=0.5G/DAY AS PART OF AN ANTIHYPERTENSIVE TREATMENT, TREATMENT OF CHRONIC HEART FAILURE IN PATIENTS >= 60 YEARS OF AGE AND REDUCING THE RISK OF STROKE IN HYPERTONIC PATIENTS WITH LEAF VENTRICULAR HYPERTROPHY BY ECG CRITERIA. |
NULL |
VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD |
DENK PHARMA GMBH & CO., LTD |
GERMANY |
CERTIFICATE RELEASED |
11 I 3977/13 |
25-SEP-2024 |
24-SEP-2029 |
View |
| 2744 |
LOSAR-DENK 50 |
LOSARTAN POTASSIUM 50 MG |
FILM-COATED TABLETS |
ALU/PVC/PE/PVDC BLISTER |
TREATMENT OF ESSENTIAL HYPERTENSION.TREATMENT OF THE RENAL DISEASE IN PATIENTS WITH HYPERTENSION AND TYPE 2 DIABETICS MELLITUS |
NULL |
VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD |
DENK PHARMA GMBH & CO., LTD |
GERMANY |
CERTIFICATE RELEASED |
11 I 3976/13 |
25-SEP-2024 |
24-SEP-2029 |
View |
| 2745 |
MAZAGE GEL |
DICLOFENAC DIETHYLAMMONIUM 1.16 G EQ.TO DICLOFENAC SODIUM 1G/100G |
GEL |
TUBE |
FOR SYMPTOMATIC RELIEF OF PAIN AND INFLAMMATION |
NULL |
VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD |
T.P DRUG LABORATORIES (1969) CO., LTD (RAMA 2 BRANCH) |
THAILAND |
CERTIFICATE RELEASED |
12 I 2706/05 |
16-JAN-2025 |
15-JAN-2030 |
View |
| 2746 |
MECOLZINE |
MESALAZINE 500 MG |
GASTRO-RESISTANT TABLETS |
PVC/PVDC/ALU BLISTER |
TREATMENT OF THE ACUTE PHASE OF MILD OR MODERATE ULCERATIVE COLITIS, MAINTENANCE TREATMENT OF REMISSION IN ULCERATIVE COLITIS, TREATMENT OF THE ACUTE PHASE OF THE CROHN'S DISEASE AND MAINTENANCE OF REMISSION OF CROHN'S DISEASE. |
NULL |
VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD |
FAES FARMA S.A. |
SPAIN |
CERTIFICATE RELEASED |
09 I 5809/24 |
25-SEP-2024 |
24-SEP-2029 |
View |
| 2747 |
METADOXIL |
METADOXINE 500 MG |
TABLET |
ALU-STRIP |
ALCOHOL FATTY LIVER |
NULL |
VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD |
INTERTHAI PHARMACEUTICAL MANUFACTURING LTD. |
THAILAND |
CERTIFICATE RELEASED |
01 I 5181/22 |
16-DEC-2024 |
15-DEC-2029 |
View |
| 2748 |
METFORMIN DENK 1000 |
METFORMIN HYDROCHLORIDE 1000 MG EQ.TO METFORMIN 780 MG |
FILM-COATED TABLET |
PVC-/PVDC-ALU BLISTERPACK |
TREATMENT OF NON-INSULIN DEPENDENT TYPE 2 DIABETES MELLITUS, PARTICULARLY IN OVERWEIGHT PATIENTS, WHEN DIETARY MANAGEMENT AND EXCERCISE ALONE DOES NOT RESULT IN ADEQUATE GLYCAEMIC CONTROL. |
NULL |
VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD |
DENK PHARMA GMBH & CO. KG |
GERMANY |
CERTIFICATE RELEASED |
02 I 3805/13 |
08-SEP-2022 |
07-SEP-2025 |
View |
| 2749 |
METFORMIN DENK 500 |
METFORMIN HYDROCHLORIDE 500 MG |
FILM-COATED TABLETS |
PVC/PVDC-ALU |
TREATMENT OF TYPE 2 DIABETES MELLITUS, PARTICULARLY IN OVERWEIGHT PATIENTS, WHEN DIETARY MANAGEMENT AND EXERCISE ALONE DOES NOT RESULT INADEQUATE GLYCAEMIC CONTROL |
NULL |
VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD |
DENK PHARMA GMBH & CO., KG |
GERMANY |
CERTIFICATE RELEASED |
08 I 4559/18 |
16-DEC-2024 |
15-DEC-2029 |
View |
| 2750 |
METFORMIN DENK 850 |
METFORMIN HYDROCHLORIDE 850 MG |
FILM-COATED TABLETS |
PVC-ALU BLISTER |
TREATMENT OF NON- INSULIN DEPENDENT TYPE 2 DIABETES MELLITUS, PARTICULARLY IN OVERWEIGHT PATIENTS, WHEN DIETARY MANAGEMENT AND EXERCISE ALONE DOES NOT RESULT IN ADEQUATE GLYCAEMIC CONTROL. |
NULL |
VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD |
DENK PHARMA GMBH & CO., LTD |
GERMANY |
CERTIFICATE RELEASED |
11 I 3969/13 |
25-SEP-2024 |
24-SEP-2029 |
View |
